North America Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Antacids, Proton Pump Inhibitors (PPIs), H2 Receptor Blockers, and Pro-kinetic Agents), By Country and Growth Forecast, 2022 - 2028

TABLE 1 North America Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 North America Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 North America Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 4 North America Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 5 North America Antacids Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Antacids Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Proton Pump Inhibitors (PPIs) Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Proton Pump Inhibitors (PPIs) Market by Country, 2022 - 2028, USD Million
TABLE 9 North America H2 Receptor Blockers Market by Country, 2018 - 2021, USD Million
TABLE 10 North America H2 Receptor Blockers Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Pro-kinetic Agents Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Pro-kinetic Agents Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Gastroesophageal Reflux Disease Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Gastroesophageal Reflux Disease Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 15 US Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 16 US Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 17 US Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 18 US Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 19 Canada Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 20 Canada Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 21 Canada Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 22 Canada Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 23 Mexico Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 24 Mexico Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 25 Mexico Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 26 Mexico Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 27 Rest of North America Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 28 Rest of North America Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 29 Rest of North America Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 30 Rest of North America Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 31 Key Information – Takeda Pharmaceutical Company Limited
TABLE 32 KEY INFORMATION – AstraZeneca PLC
TABLE 33 Key Information – GlaxoSmithKline PLC
TABLE 34 Key information –Johnson & Johnson
TABLE 35 Key Information – Ironwood Pharmaceuticals, Inc.
TABLE 36 Key Information – Eisai Co., Ltd.
TABLE 37 Key Information – Medigus Ltd.
TABLE 38 Key Information – Sebela Pharmaceuticals
TABLE 39 Key Information – Phathom Pharmaceuticals, Inc.
TABLE 40 Key Information – Camber Pharmaceuticals, Inc.

List of Figures
FIG 1 Methodology for the research